Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Vancomycin
100%
Gram-positive Pathogens
100%
Community-acquired Pneumonia
100%
Telavancin
100%
Cure Rate
55%
95% Confidence Interval
44%
Clinical Response
22%
Methicillin-resistant Staphylococcus Aureus
11%
Treatment Group
11%
Mortality Rate
11%
Adverse Events
11%
Gram-negative Infections
11%
Gram-positive
11%
Serum Creatinine Level
11%
Methicillin-resistant Staphylococcus Aureus Infection
11%
Lipoglycopeptide
11%
S. Aureus Infection
11%
Monomicrobial
11%
Test of Cure
11%
Follow-up Test
11%
Medicine and Dentistry
Pathogen
100%
Vancomycin
100%
Telavancin
100%
Hospital-Acquired Pneumonia
100%
Mortality Rate
11%
Infection
11%
Staphylococcus Aureus
11%
Methicillin Resistant Staphylococcus Aureus
11%
Creatinine
11%
Methicillin Resistant Staphylococcus Aureus Infection
11%
Treatment Group
11%
Lipoglycopeptide
11%
Gram-Negative Bacterial Infection
11%
Adverse Event
11%
Nursing and Health Professions
Vancomycin
100%
Hospital Acquired Pneumonia
100%
Telavancin
100%
Confidence Interval
44%
Methicillin-Resistant Staphylococcus Aureus
11%
Adverse Event
11%
Infection
11%
Mortality Rate
11%
Creatinine Blood Level
11%
Methicillin Resistant Staphylococcus Aureus Infection
11%
Treatment Group
11%
Gram Negative Infection
11%
Immunology and Microbiology
Infectious Agent
100%
Infectious Disease
75%
Infection
75%
Methicillin-Resistant Staphylococcus Aureus
50%
Staphylococcus Aureus
25%
Mortality Rate
25%
Creatinine Blood Level
25%
Neuroscience
Vancomycin
100%
Telavancin
100%
Pneumonia
100%
Methicillin-Resistant Staphylococcus Aureus
22%
Creatinine
11%
Lipoglycopeptide
11%